FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
about
IgA function--variations on a theme.Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) bindingAnti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells.The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cellsA comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.Immunoglobulin A: A next generation of therapeutic antibodies?IgA EGFR antibodies mediate tumour killing in vivo.Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake.Human Cell Line-Derived Monoclonal IgA Antibodies for Cancer Immunotherapy.The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding.Cloning and characterization of an immunoglobulin A Fc receptor from cattle.CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.
P2860
Q35893307-3543BB94-7DDD-4C53-A451-4893F40BEC02Q36216363-508ABAB1-ADE9-46A9-9DFC-FB5D618D6EF5Q36366594-47B95E60-F49B-4F1D-8FF9-5DE21BFFF7DCQ36621733-6434C8F8-9B0D-4C22-A626-A7DE980F2A3EQ37138274-7A240918-9C92-4D0F-8B2B-79DFC87B779FQ37892323-1364573B-7995-4498-8E17-29C91BEA2A5BQ39114924-67B82256-BD20-4575-B84B-6418CBA47AA1Q40300686-EF723D7B-0A6D-4122-A1CF-6E763FFBBCACQ41704272-CED03266-D779-4ADE-AB80-8400FF00B8D1Q47731094-DD515B41-C1FA-42E3-8089-3158EA3EACE6Q47933555-0D6E1FF7-C437-4950-A8A7-6D3D426ECEA6Q52731744-88E8F626-071B-44DF-B0CF-1C0D398E953B
P2860
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
@en
FcalphaRI
@nl
type
label
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
@en
FcalphaRI
@nl
prefLabel
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
@en
FcalphaRI
@nl
P2093
P1433
P1476
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
@en
P2093
Gramatzki M
Graziano RF
Stockmeyer B
Valerius T
van Spriel AB
van de Winkel JG
P304
P407
P577
1997-12-01T00:00:00Z